GSTM1 and anemia: No adverse events were reported in either arm of the study [24]. Qassim et al. in a retrospective cohort study found that intravenous iron supplementation was effective in improving maternal hematological parameters and reducing iron deficiency anemia during delivery and, compared to oral iron, produced a greater rise in Hb at delivery [25].